ON DEMAND - LAAO SUMMIT 2023
12th Global Left Atrial Appendage Occlusion Summit
LAAO SUMMIT 2023 - Welcome
Left Atrial Appendage Occlusion therapy has become an established and increasingly…
Check if your logged user sees the right products.
Check if your logged user sees the right videos.
© Abbott 2023. All rights reserved. 9-EH-5-14585-01 10-2023
HEART FAILURE MANAGEMENT OPTIONS
Management options for heart failure may include a combination of lifestyle changes, medications, implantable devices such as a pacemaker or defibrillator providing…
While there is no true cure for heart failure, today’s therapies and monitoring options help more people than ever to manage their heart failure, live longer and improve their quality of life.
© Abbott 2023. All rights reserved. 9-EH-5-14558-01 09-2023
Visit our dedicated channel for the latest videos, animations and interviews.
Find out more
Real-world evidence shows a significant relationship between degree of residual MR and survival after transcatheter mitral repair. Tendyne™ is an option for select MR patients who may benefit from…
49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year…
MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be…